Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Morphic Holding Inc (NQ: MORF ) 56.99 UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Morphic Holding Inc < Previous 1 2 3 4 5 Next > Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday July 08, 2024 Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Morphic Holding, Inc. (Nasdaq - MORF), Desktop Metal, Inc. (NYSE - DM), Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR) July 08, 2024 From Brodsky & Smith LLC Via GlobeNewswire Dow Jumps Over 200 Points; Greenbrier Shares Fall After Q3 Results July 08, 2024 Via Benzinga Topics Stocks Exposures US Equities Recap: Morphic Holding Q4 Earnings February 22, 2024 Via Benzinga Eli Lilly's First Biotech Deal Of 2024, Buys Chronic Disease Player Morphic For $3.2B July 08, 2024 Eli Lilly to acquire Morphic Holding Inc for $3.2 billion, strengthening its portfolio in chronic disease treatments. Morphic's lead program, MORF-057, targets inflammatory bowel disease, with... Via Benzinga Eli Lilly Snaps Up Morphic At 79% Premium July 08, 2024 Eli Lilly said Monday it would pay $3.2 billion to acquire an innovator in oral treatments for chronic bowel diseases. Via Investor's Business Daily Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday July 08, 2024 It's time to start the week with a breakdown of the biggest pre-market stock movers traders will want to know about on Monday! Via InvestorPlace MORF Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Morphic Holding, Inc. Is Fair to Shareholders July 08, 2024 From Halper Sadeh LLC Via Business Wire Morphic to Participate in Jefferies Global Healthcare Conference May 31, 2024 From Morphic Therapeutic Via GlobeNewswire Morphic Demonstrates Novel Real-Time Visualization of Small Molecule α4β7 Inhibition of Gut-Trafficking Cells May 21, 2024 From Morphic Therapeutic Via GlobeNewswire Morphic to Participate in RBC Capital Markets Global Healthcare Conference May 09, 2024 From Morphic Therapeutic Via GlobeNewswire MORF Stock Earnings: Morphic Holding Beats EPS for Q1 2024 April 25, 2024 MORF stock results show that Morphic Holding beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024 April 25, 2024 From Morphic Therapeutic Via GlobeNewswire Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings April 02, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings March 26, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire MORF Investor Notice: Abraham, Fruchter & Twersky, LLP Investigating Claims on Behalf of Investors of Morphic Holding, Inc. (NASDAQ:MORF) March 20, 2024 From Abraham, Fruchter & Twersky, LLP Via GlobeNewswire Morphic Appoints Dr. Simon Cooper as Chief Medical Officer March 19, 2024 Experienced Clinical Development Leader with Deep Experience in Immunology and Inflammatory Diseases From Morphic Therapeutic Via GlobeNewswire Morphic to Participate in March Investor Conferences March 05, 2024 From Morphic Therapeutic Via GlobeNewswire Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023 February 22, 2024 From Morphic Therapeutic Via GlobeNewswire INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors January 11, 2024 From Law Offices of Howard G. Smith Via Business Wire Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors January 10, 2024 From Glancy Prongay & Murray LLP Via Business Wire The Law Offices of Frank R. Cruz Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors January 04, 2024 From The Law Offices of Frank R. Cruz Via Business Wire Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From Morphic Therapeutic Via GlobeNewswire Robbins LLP Reminds MORF Investors that it is Investigating Morphic Holdings, Inc. on Behalf of Investors December 01, 2023 From Robbins LLP Via Business Wire Morphic Holding, Inc. Reminder: Robbins LLP is Investigating MORF on Behalf of Investors November 22, 2023 From Robbins LLP Via Business Wire Morphic to Present at November Investor Conferences November 10, 2023 From Morphic Therapeutic Via GlobeNewswire Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023 November 03, 2023 From Morphic Therapeutic Via GlobeNewswire NASDAQ: MORF Investor Notice: Investigation over Possible Securities Laws Violations by Morphic Holding, Inc. November 01, 2023 San Diego, CA -- (SBWIRE) -- 11/01/2023 -- Morphic Holding, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. Via SBWire Morphic Holding Investigation: Johnson Fistel Encourages Shareholders with Losses to Contact the Firm Regarding Investigation October 21, 2023 From Johnson Fistel, LLP Via Business Wire Morphic Holding SHAREHOLDER ALERT: Johnson Fistel Encourages Morphic Holding Shareholders with Losses to Contact the Firm Regarding Investigation October 14, 2023 From Johnson Fistel, LLP Via Business Wire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.